KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 143 filers reported holding KARYOPHARM THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 1.33 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $456,000 | -77.2% | 29,429 | -71.7% | 0.09% | -81.2% |
| Q4 2019 | $1,996,000 | +77.0% | 104,100 | -11.2% | 0.49% | +56.2% |
| Q3 2019 | $1,128,000 | -64.3% | 117,250 | -77.7% | 0.31% | -64.9% |
| Q2 2019 | $3,156,000 | +21.5% | 526,900 | +18.4% | 0.89% | +13.6% |
| Q1 2019 | $2,598,000 | -37.7% | 444,900 | 0.0% | 0.79% | -47.4% |
| Q4 2018 | $4,169,000 | -48.3% | 444,900 | -6.1% | 1.50% | -32.9% |
| Q3 2018 | $8,071,000 | +13.9% | 473,901 | +13.7% | 2.23% | +0.4% |
| Q2 2018 | $7,083,000 | – | 416,900 | – | 2.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 3,561,052 | $26,245,000 | 5.86% |
| Palo Alto Investors LP | 5,621,533 | $41,431,000 | 3.20% |
| Iron Triangle Partners LP | 2,000,000 | $14,740,000 | 1.75% |
| Altium Capital Management LP | 645,000 | $4,754,000 | 1.59% |
| Birchview Capital, LP | 269,332 | $1,985,000 | 1.43% |
| Rubric Capital Management LP | 3,607,443 | $26,587,000 | 0.96% |
| Lombard Odier Asset Management (Switzerland) SA | 776,053 | $5,720,000 | 0.45% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,344,929 | $9,912,000 | 0.40% |
| Golden State Equity Partners | 41,850 | $308,000 | 0.16% |
| Hennion & Walsh Asset Management, Inc. | 385,837 | $2,844,000 | 0.15% |